mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.7 |
0.01 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |